Quarterly report pursuant to Section 13 or 15(d)

4. LICENSE AGREEMENT OBLIGATION

v3.3.1.900
4. LICENSE AGREEMENT OBLIGATION
9 Months Ended
Jan. 31, 2016
Research and Development [Abstract]  
4. LICENSE AGREEMENT OBLIGATION

The Company entered into a licensing agreement for a license to use the Cell-in-a-Box® technology to develop therapies involving the constituents of the Cannabis plant. As of January 31, 2016, the Company owes $300,000 out of a total required $2,000,000 “Upfront Payment” for the license (see Note 8).